Steroid therapy in an alpha-dystroglycanopathy due to GMPPB gene mutations: A case report
暂无分享,去创建一个
G. Andria | G. Parenti | P. Strisciuglio | A. Torella | V. Nigro | M. Savarese | S. Fecarotta | V. Gragnaniello | A. Romano | R. Della Casa | E. Raiano
[1] T. Toda,et al. Mechanistic aspects of the formation of α-dystroglycan and therapeutic research for the treatment of α-dystroglycanopathy: A review. , 2016, Molecular aspects of medicine.
[2] Yubo Sun,et al. Glucocorticoid Steroid and Alendronate Treatment Alleviates Dystrophic Phenotype with Enhanced Functional Glycosylation of α-Dystroglycan in Mouse Model of Limb-Girdle Muscular Dystrophy with FKRPP448L Mutation. , 2016, The American journal of pathology.
[3] K. Bushby,et al. This Work Is Licensed under a Creative Commons Attribution 4.0 International License Mutations in Gmppb Cause Congenital Myasthenic Syndrome and Bridge Myasthenic Disorders with Dystroglycanopathies , 2022 .
[4] D. MacArthur,et al. Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan. , 2013, American journal of human genetics.
[5] Yen-Mou Lu,et al. Strength and Functional Measurement for Patients with Muscular Dystrophy , 2012 .
[6] R. Finkel,et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management , 2010, The Lancet Neurology.
[7] N. Darín,et al. Inflammation and response to steroid treatment in limb-girdle muscular dystrophy 2I. , 2007, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[8] Susan C. Brown,et al. Fukutin gene mutations in steroid‐responsive limb girdle muscular dystrophy , 2006, Annals of neurology.
[9] Jacques Fermanian,et al. A motor function measure scale for neuromuscular diseases. Construction and validation study , 2005, Neuromuscular Disorders.
[10] A. Engel,et al. Unexpected sarcolemmal complement membrane attack complex deposits on nonnecrotic muscle fibers in muscular dystrophies , 1998, Neurology.
[11] K. Davies,et al. The effect of glucocorticoids on the accumulation of utrophin by cultured normal and dystrophic human skeletal muscle satellite cells , 1995, Neuromuscular Disorders.
[12] R. Sklar,et al. Methylprednisolone increases dystrophin levels by inhibiting myotube death during myogenesis of normal human muscle in vitro , 1991, Journal of the Neurological Sciences.
[13] R. Griggs,et al. Effect of prednisone on protein metabolism in Duchenne dystrophy. , 1995, The American journal of physiology.